BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 30524424)

  • 1. Baseline Gastrointestinal Eosinophilia Is Common in Oral Immunotherapy Subjects With IgE-Mediated Peanut Allergy.
    Wright BL; Fernandez-Becker NQ; Kambham N; Purington N; Tupa D; Zhang W; Rank MA; Kita H; Shim KP; Bunning BJ; Doyle AD; Jacobsen EA; Boyd SD; Tsai M; Maecker H; Manohar M; Galli SJ; Nadeau KC; Chinthrajah RS
    Front Immunol; 2018; 9():2624. PubMed ID: 30524424
    [No Abstract]   [Full Text] [Related]  

  • 2. Gastrointestinal Eosinophil Responses in a Longitudinal, Randomized Trial of Peanut Oral Immunotherapy.
    Wright BL; Fernandez-Becker NQ; Kambham N; Purington N; Cao S; Tupa D; Zhang W; Sindher SB; Rank MA; Kita H; Katzka DA; Shim KP; Bunning BJ; Doyle AD; Jacobsen EA; Tsai M; Boyd SD; Manohar M; Chinthrajah RS
    Clin Gastroenterol Hepatol; 2021 Jun; 19(6):1151-1159.e14. PubMed ID: 32434067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of gastric eosinophilia by epicutaneous immunotherapy in piglets sensitized to peanuts.
    Mondoulet L; Kalach N; Dhelft V; Larcher T; Delayre-Orthez C; Benhamou PH; Spergel J; Sampson HA; Dupont C
    Clin Exp Allergy; 2017 Dec; 47(12):1640-1647. PubMed ID: 28960628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Image Analysis of Eosinophil Peroxidase Immunohistochemistry for Diagnosis of Eosinophilic Esophagitis.
    Wright BL; Doyle AD; Shim KP; Pai RK; Barshow SM; Horsley-Silva JL; Luo H; Rank MA; Jacobsen EA; Katzka DA; Kita H; Dellon ES
    Dig Dis Sci; 2021 Mar; 66(3):775-783. PubMed ID: 32248390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allergen-specific oral immunotherapy for peanut allergy.
    Nurmatov U; Venderbosch I; Devereux G; Simons FE; Sheikh A
    Cochrane Database Syst Rev; 2012 Sep; (9):CD009014. PubMed ID: 22972130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Food-Specific IgG4 Is Elevated Throughout the Upper Gastrointestinal Tract in Eosinophilic Esophagitis.
    Masuda MY; LeSuer WE; Horsley-Silva JL; Putikova A; Buras MR; Gibson JB; Pyon GC; Simmons TD; Doyle AD; Wright BL
    Dig Dis Sci; 2023 Jun; 68(6):2406-2413. PubMed ID: 36973521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary eosinophilic gastrointestinal disorders in children who have received food oral immunotherapy.
    Echeverría-Zudaire LÁ; Fernández-Fernández S; Rayo-Fernández A; Muñóz-Archidona C; Checa-Rodriguez R
    Allergol Immunopathol (Madr); 2016; 44(6):531-536. PubMed ID: 27592279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of Pediatric Non-Esophageal Eosinophilic Gastrointestinal Disorders by Eosinophil Peroxidase Immunohistochemistry.
    Hasan SH; Taylor S; Garg S; Buras MR; Doyle AD; Bauer CS; Wright BL; Schroeder S
    Pediatr Dev Pathol; 2021; 24(6):513-522. PubMed ID: 34176359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peanut gastrointestinal delivery oral immunotherapy in adolescents: Results of the build-up phase of a randomized, double-blind, placebo-controlled trial (PITA study).
    Fauquert JL; Michaud E; Pereira B; Bernard L; Gourdon-Dubois N; Rouzaire PO; Rochette E; Merlin E; Evrard B;
    Clin Exp Allergy; 2018 Jul; 48(7):862-874. PubMed ID: 29665158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose oral immunotherapy for children with anaphylactic peanut allergy in Japan.
    Nagakura KI; Yanagida N; Sato S; Nishino M; Asaumi T; Ogura K; Ebisawa M
    Pediatr Allergy Immunol; 2018 Aug; 29(5):512-518. PubMed ID: 29603410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eosinophils in Eosinophilic Esophagitis: The Road to Fibrostenosis is Paved With Good Intentions.
    Doyle AD; Masuda MY; Kita H; Wright BL
    Front Immunol; 2020; 11():603295. PubMed ID: 33335531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgE binding to linear epitopes of Ara h 2 in peanut allergic preschool children undergoing oral Immunotherapy.
    Dreskin SC; Germinaro M; Reinhold D; Chen X; Vickery BP; Kulis M; Burks AW; Negi SS; Braun W; Chambliss JM; Eglite S; McNulty CMG
    Pediatr Allergy Immunol; 2019 Dec; 30(8):817-823. PubMed ID: 31437325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking antibodies induced by peanut oral and sublingual immunotherapy suppress basophil activation and are associated with sustained unresponsiveness.
    Orgel K; Burk C; Smeekens J; Suber J; Hardy L; Guo R; Burks AW; Kulis M
    Clin Exp Allergy; 2019 Apr; 49(4):461-470. PubMed ID: 30383313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eosinophil-Associated Gastrointestinal Manifestations During OIT.
    Goldberg MR; Epstein-Rigbi N; Elizur A
    Clin Rev Allergy Immunol; 2023 Dec; 65(3):365-376. PubMed ID: 37957456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of oral immunotherapy treatment in severe IgE mediated milk, peanut, and egg allergy in adults.
    Mäntylä J; Thomander T; Hakulinen A; Kukkonen K; Palosuo K; Voutilainen H; Pelkonen A; Kauppi P
    Immun Inflamm Dis; 2018 Jun; 6(2):307-311. PubMed ID: 29542268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eosinophil counts in upper digestive mucosa of Western European children: variations with age, organs, symptoms, Helicobacter pylori status, and pathological findings.
    Kalach N; Huvenne H; Gosset P; Papadopoulos S; Dehecq E; Decoster A; Creusy C; Dupont C
    J Pediatr Gastroenterol Nutr; 2011 Feb; 52(2):175-82. PubMed ID: 20890222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probiotic peanut oral immunotherapy versus oral immunotherapy and placebo in children with peanut allergy in Australia (PPOIT-003): a multicentre, randomised, phase 2b trial.
    Loke P; Orsini F; Lozinsky AC; Gold M; O'Sullivan MD; Quinn P; Lloyd M; Ashley SE; Pitkin S; Axelrad C; Metcalfe JR; Su EL; Tey D; Robinson MN; Allen KJ; Prescott SL; Galvin AD; Tang MLK;
    Lancet Child Adolesc Health; 2022 Mar; 6(3):171-184. PubMed ID: 35123664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective.
    Vickery BP; Berglund JP; Burk CM; Fine JP; Kim EH; Kim JI; Keet CA; Kulis M; Orgel KG; Guo R; Steele PH; Virkud YV; Ye P; Wright BL; Wood RA; Burks AW
    J Allergy Clin Immunol; 2017 Jan; 139(1):173-181.e8. PubMed ID: 27522159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of a probiotic with peanut oral immunotherapy: A randomized trial.
    Tang ML; Ponsonby AL; Orsini F; Tey D; Robinson M; Su EL; Licciardi P; Burks W; Donath S
    J Allergy Clin Immunol; 2015 Mar; 135(3):737-44.e8. PubMed ID: 25592987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy.
    Narisety SD; Frischmeyer-Guerrerio PA; Keet CA; Gorelik M; Schroeder J; Hamilton RG; Wood RA
    J Allergy Clin Immunol; 2015 May; 135(5):1275-82.e1-6. PubMed ID: 25528358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.